XML 49 R39.htm IDEA: XBRL DOCUMENT v3.22.4
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Jul. 14, 2022
Jul. 08, 2021
Feb. 11, 2021
Mar. 17, 2022
Sep. 30, 2022
Sep. 30, 2021
Jun. 30, 2022
Jul. 21, 2020
Jul. 08, 2020
Feb. 06, 2014
Subsidiary, Sale of Stock [Line Items]                    
Preferred Stock, Shares Authorized         10,000,000   10,000,000      
Preferred Stock, Par or Stated Value Per Share         $ 0.0001   $ 0.0001      
Preferred Stock, Shares Outstanding         0   0      
Common stock, shares authorized         100,000,000   100,000,000      
Common stock, par value         $ 0.0001   $ 0.0001      
Common stock, shares issued         55,507,082   53,007,082      
Common stock, shares outstanding         55,507,082   53,007,082      
Obligation to purchase                 $ 20,000,000  
Maturity date   Aug. 01, 2023 Nov. 30, 2022              
Issued shares       47,115 74,054          
Proceeds from Issuance of Common Stock       $ 299,178            
Extinguishment of contingent consideration liability         $ 419,182          
Common stock reserved for issuance         17,414          
Stock based compensation expense         $ 1,026,008 $ 2,727,975        
Unrecognized compensation cost         5,485,468          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value         0          
Share-Based Payment Arrangement, Noncash Expense         $ 1,026,008 $ 2,727,975        
Share-Based Payment Arrangement, Option [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number         1,914,007          
Black Scholes [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Number of option issued           24,500        
Restricted Stock [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Share-Based Payment Arrangement, Noncash Expense         $ 0 $ 2,991        
Restricted Stock Units (RSUs) [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Unrecognized compensation cost         $ 0          
2014 Equity Incentive Plan [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Common stock reserved for issuance                   1,206,000
Plan Options [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Option available to be issued         2,679,848          
Option granted         5,106,000          
Warrant [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Stock Repurchased During Period, Shares 1,250,000                  
Proceeds from Issuance of Common Stock $ 1,625,000                  
Share Price $ 2.21                  
Noncash or Part Noncash Acquisition, Accounts Receivable Acquired $ 2,762,500                  
Common Stock [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Share-Based Payment Arrangement, Noncash Expense                
Agreement And Plan Of Merger Agreement Axis [Member] | E B I And Weird Science L L C [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Common shares contingently issuable         0          
Lincoln Park [Member] | Purchase Agreement [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Option available to be issued         0 0        
Remaining value available under purchase agreement         $ 14,102,251          
Enochian Bio Pharma Inc [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Stock Issued During Period, Shares, Period Increase (Decrease)         2,500,000 0        
DanDrit Denmark [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Common stock, shares outstanding         167,639          
Stock Issued During Period, Shares, Period Increase (Decrease)         0          
Employees [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Option granted         73,200 0        
Employees [Member] | N 2019 Equity Incentive Plan [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Option granted         0 3,009,300        
Employees [Member] | Common Stock [Member] | N 2019 Equity Incentive Plan [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Option granted         184,800 0        
Board Of Directors And Scientific Advisory Board [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Option granted         50,958 26,735        
Consulting Services 2 [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Option granted         0 21,979        
Consulting Services 1 [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Option granted         0          
Purchase Agreement [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Issued shares               139,567